详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Zhang Xiaoshuai[1] * ; Gale Robert Peter[2] ; Liu Bingcheng[3] ; Huang Jian[4] ; Zhang Yanli[5] ; Du Xin[6] ; Weng Jianyu[7] ; Li Weiming[8] ; Xu Na[9] ; Liu Xiaoli[9] ; Chen Chunyan[10] ; Lin Hai[11] ; Li Guohui[12] ; Liang Rong[13] ; Liu Zhuogang[14] ; Wang Xiaodong[15] ; Zhang Yanqing[16] ; Han Yanqiu[17] ; Liu Chunshui[18] ; Hu Jianda[19] ; Lin Lie[20] ; Yang Wei[14] ; Liu Zhenfang[21] ; Meng Li[22] ; Tu Chuanqing[23] ; Zheng Caifeng[23] ; Zhou Zeping[24] ; Bai Yanliang[25] ; Qiu Huiying[26] ; Chen Suning[26] ; Li Fei[27] ; Guo Jianxin[28] ; Liu Zelin[29] ; Sun Hui[30] ; Zhou Li[31] ; Feng Ru[32] ; Sun Xiuli[33] ; Huang Xiaojun[34,35,36,37] ; Jiang Qian[38,39] ;

机构： [1]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. [2]Centre for Hematology Research, Department of Immunology and Inflammation, Imperial College London, London, UK. [3]National Clinical Research Center for Blood Diseases, Institute of Hematology &Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China. [4]Department of Hematology, he First Affiliated Hospital of Zhejiang University, College of Medicine, Zhejiang University, Department of Hematology, The Fourth Affiliated Hospital of Zhejiang University, College of Medicine, Zhejiang University, Zhejiang Provincial Clinical Research Center for Haematological Disorders, Zhejiang, China. [5]Henan Cancer Hospital, The Affiliate Cancer Hospital of Zhengzhou University, Zhengzhou, Henan, China. [6]Division of Hematology, Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University, Guangdong, China. [7]Department of Hematology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China. [8]Union hospital, Tongji Medical college, Huazhong University of Science and Technology, Wuhan, China. [9]Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. [10]Department of Hematology, Qilu Hospital of Shandong University, Jinan, China. [11]Department of hematology, First Hospital of Jilin University, Jilin, China. [12]Xi'an international medical center hospital, Shanxi, China. [13]Department of Hematology, Xijing Hospital, Airforce Military Medical University, Shanxi, China. [14]Shengjing Hospital of China Medical University, Shenyang, China. [15]Sichuan Academy of Medical Sciences Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. [16]Department of Hematology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China. [17]The affiliated hospital of Inner Mongolia Medical University, Inner Mongolia, China. [18]Department of Hematology, Cancer Center, The First Hospital of Jilin University, Changchun, China. [19]Fujian Institute of Hematology, Fujian Provincial Key Laboratory of Hematology, Fujian Medical University Union Hospital, Fujian, China. [20]Department of Hematology, Hainan General Hospital, Hainan Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China. [21]Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. [22]Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. [23]Department of Hematology, Shenzhen Baoan Hospital, Shenzhen University Second Affiliated Hospital, Shenzhen, China. [24]Department of Hematology, the Second Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China. [25]Department of Hematology, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, Henan, China. [26]National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation of Soochow University, Suzhou, China. [27]Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China. [28]Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Fujian, China. [29]Department of Hematology, Huazhong University of Science and Technology Union Shenzhen Hospital (Nanshan Hospital), Shenzhen, China. [30]Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. [31]Department of Leukemia, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. [32]Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China. [33]Department of hematology, The first affiliated hospital of Dalian Medical University, Dalian, China. [34]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. huangxiaojun@bjmu.edu.cn. [35]Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. huangxiaojun@bjmu.edu.cn. [36]Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 1, China. huangxiaojun@bjmu.edu.cn. [37]Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China. huangxiaojun@bjmu.edu.cn. [38]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. jiangqian@medmail.com.cn. [39]Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. jiangqian@medmail.com.cn.

出处：

DOI：

ISSN：

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区血液学 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区血液学 1 区肿瘤学

第一作者：

第一作者机构： [1]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.

通讯作者：

通讯机构： [34]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. huangxiaojun@bjmu.edu.cn. [35]Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. huangxiaojun@bjmu.edu.cn. [36]Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 1, China. huangxiaojun@bjmu.edu.cn. [37]Research Unit of Key Technique for Diagnosis and Treatments of Hematologic Malignancies, Chinese Academy of Medical Sciences, Beijing, China. huangxiaojun@bjmu.edu.cn. [38]Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. jiangqian@medmail.com.cn. [39]Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China. jiangqian@medmail.com.cn.

推荐引用方式(GB/T 7714)：

APA：

MLA：

Validation of the imatinib-therapy failure model

文献详情